Dose-escalation Study of Oral Administration of S 55746 in Patients With Chronic Lymphocytic Leukaemia and B-Cell Non-Hodgkin Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Steven Le Gouill, M.D., Ph.D.
Nantes University Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Alfred Hospital Malignant Haematology & Stem Cell Transplantation Services
Melbourne, Australia
- Hopital Claude Huriez
Lille, France
- Chu de Nantes
Nantes, France
- Centre Hospitalier Lyon Sud
Pierre-Bénite, France
- Gustave Roussy
Villejuif, France
- Universitätsklinikum Carl Gustav Carus
Dresden, Germany
- Städtisches Klinikum Schwabing
Munich, Germany
- Universitätsklinikum Ulm
Ulm, Germany
- National Oncology Institute
Budapest, Hungary
- Cru Hungary Kft
Miskolc, Hungary
- Warsaw Institute of Oncology
Warsaw, Poland
- Warsaw Medical University
Warsaw, Poland
- National Cancer Center (ncc)
Singapore, Singapore
- National University Cancer Institute Singapore
Singapore, Singapore
- Severance Hospital
Seoul, South Korea
- St. Mary'S Hospital
Seoul, South Korea
- University College London Hospitals
London, United Kingdom
- Freeman Hospital
Newcastle, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2014
- Primary completion
- 22 Oct 2018
- Completion
- 22 Oct 2018
- Last update posted
- 25 Jul 2024
- Registered enrollment
- 65
- Registry id
- NCT02920697
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.